[go: up one dir, main page]

ES2141044B1 - OXIBUTININE THERAPY. - Google Patents

OXIBUTININE THERAPY.

Info

Publication number
ES2141044B1
ES2141044B1 ES9800339A ES9800339A ES2141044B1 ES 2141044 B1 ES2141044 B1 ES 2141044B1 ES 9800339 A ES9800339 A ES 9800339A ES 9800339 A ES9800339 A ES 9800339A ES 2141044 B1 ES2141044 B1 ES 2141044B1
Authority
ES
Spain
Prior art keywords
therapy
oxibutinine
oxybutynin
composition
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9800339A
Other languages
Spanish (es)
Other versions
ES2141044A1 (en
Inventor
George V Guittard
Francisco Jao
Susan M Marks
David J Kidney
Fernando Gumucio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/806,773 external-priority patent/US5912268A/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES2141044A1 publication Critical patent/ES2141044A1/en
Application granted granted Critical
Publication of ES2141044B1 publication Critical patent/ES2141044B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Terapia con oxibutinina. Se describen una composición que incluye oxibutinina, un dispositivo que incluye oxibutinina, y un método para administrar oxibutinina, para terapia con oxibutinina.Oxybutynin therapy. A composition that includes oxybutynin, a device that includes oxybutynin, and a method for administering oxybutynin, for oxybutynin therapy are described.

ES9800339A 1997-02-26 1998-02-19 OXIBUTININE THERAPY. Expired - Fee Related ES2141044B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/806,773 US5912268A (en) 1995-05-22 1997-02-26 Dosage form and method for treating incontinence

Publications (2)

Publication Number Publication Date
ES2141044A1 ES2141044A1 (en) 2000-03-01
ES2141044B1 true ES2141044B1 (en) 2001-02-01

Family

ID=25194814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800339A Expired - Fee Related ES2141044B1 (en) 1997-02-26 1998-02-19 OXIBUTININE THERAPY.

Country Status (1)

Country Link
ES (1) ES2141044B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665858B2 (en) * 1992-05-30 1997-10-22 日本ヘキスト・マリオン・ルセル株式会社 Long-acting oxybutynin hydrochloride preparation
JP2646170B2 (en) * 1992-06-24 1997-08-25 日本ヘキスト・マリオン・ルセル株式会社 Sustained-release oxybutynin hydrochloride preparation
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin

Also Published As

Publication number Publication date
ES2141044A1 (en) 2000-03-01

Similar Documents

Publication Publication Date Title
TR200100922T2 (en) Application of active substances through the lungs.
GB2318055A (en) Dosage form comprising oxybutynin
DK1037634T3 (en) Oral administration comprising a proton pump inhibitor (e.g. pantoprazo)
ATE264863T1 (en) 28-EPIRAPALOGUE
MX9306499A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN AMPHETAMINE.
NO991524L (en) vaccinations
EE9700195A (en) An oral pharmaceutical dosage form comprising a proton pump inhibitor and a prokinetic agent
DK1036058T3 (en) adamantane
DE69808130D1 (en) Adamantane derivatives
EE9700194A (en) An oral pharmaceutical dosage form comprising a proton pump inhibitor and an NSAID
EA199800857A1 (en) COMPOSITION FOR REMOVAL OF PAIN AND METHOD OF REMOVAL OF PAIN
ES551119A0 (en) PROCEDURE FOR PREPARING AN ANALGESICALLY ACTIVE AGENT BASED ON 2-AMINO-3-CARBOETOXIAMINO-6- (4-FLUOROBENCILAMINO) -PIRIDINE AND AT LEAST ONE NON-STEROIDAL ANTIFLOGISTIC AGENT
ES2181168T3 (en) SOLID BLENDS BASED ON SULFONILE AND ADJUSTERS.
ES2145373T3 (en) PROCEDURE FOR THE DEVELOPMENT OF TRAMADOL RACEMATE.
DE69625230D1 (en) thrombin inhibitors
ES2179529T3 (en) BIAROMATIC COMPOUNDS UNITED BY A HETEROETYLLENE RADICAL, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM.
ES2141044B1 (en) OXIBUTININE THERAPY.
AR018321A1 (en) A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION.
EA200000112A1 (en) NEW COMPOSITION
ATE323493T1 (en) CONTROLLED RELEASE OF ANTIDEPRESSANTS
AU9294698A (en) Methods and compositions for enhanced wound healing
CO5170459A1 (en) TRANSDERMAL THERAPY WITH LON-OL STROGEN AGONISTS-ANTAGONISTS, ADMINISTERED BY TRANSDERMAL MEDIA
EP0618232A3 (en) Substance BS-3, an anti-oxidant for fats and an analgesic.
NO981320L (en) Oral use of (+) - O-demethyltramadol as a pain reliever
ES1025548Y (en) ARMCHAIR FOR DENTAL EQUIPMENT.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000301

Kind code of ref document: A1

Effective date: 20000301

FD2A Announcement of lapse in spain

Effective date: 20180525